| 0.838 -0.143 (-14.58%) | 12-15 15:59 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.26 | 1-year : | 1.51 |
| Resists | First : | 1.08 | Second : | 1.29 |
| Pivot price | 0.88  |
|||
| Supports | First : | 0.74 | Second : | 0.61 |
| MAs | MA(5) : | 0.9 |
MA(20) : | 0.86 |
| MA(100) : | 1.36 |
MA(250) : | 0 | |
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 36.1 |
D(3) : | 45.8 |
| RSI | RSI(14): 42.2 |
|||
| 52-week | High : | 2.86 | Low : | 0.62 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ ADGM ] has closed above bottom band by 27.4%. Bollinger Bands are 64.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 15 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.98 - 0.99 | 0.99 - 0.99 |
| Low: | 0.8 - 0.8 | 0.8 - 0.81 |
| Close: | 0.83 - 0.84 | 0.84 - 0.84 |
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.
Thu, 11 Dec 2025
Adagio Medical Holdings appoints Sean Salmon to board of directors - Investing.com
Fri, 14 Nov 2025
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Mon, 20 Oct 2025
Adagio Medical closes $50 million private placement to fund FDA efforts - Investing.com
Wed, 15 Oct 2025
Adagio Medical raises $19 million in private placement - Investing.com
Fri, 10 Oct 2025
Adagio Medical reports 97% acute success in ventricular tachycardia study - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 0 (M) |
| Shares Float | 21 (M) |
| Held by Insiders | 5.94e+006 (%) |
| Held by Institutions | 8 (%) |
| Shares Short | 505 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -2.562e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -19 % |
| Return on Assets (ttm) | 543.7 % |
| Return on Equity (ttm) | -24.2 % |
| Qtrly Rev. Growth | 137000 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | -1314.75 |
| EBITDA (p.s.) | -1.25625e+007 |
| Qtrly Earnings Growth | -2.3 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -22 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.01 |
| Price to Cash Flow | -1.49 |
| Dividend | 0 |
| Forward Dividend | 387660 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|